InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-9.4%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Nolan Sean P., Director. Insider active across 3 companies, notably Taysha Gene Therapies, Inc.. Aggregated, 13 filings have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €411k. History available since 20 May 2021. The latest transaction was disclosed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
2,047 shares@ US$90.350.0004% mcap100.0% of flowCommon StockSEC:0001569926-26-000012
2,047 shares@ US$90.350.0004% mcap32.8% of flowCommon StockSEC:0001569926-26-000012:0
2,882 shares@ US$64.1817.1% of flowCommon StockSEC:0000740260-25-000175:0
892,500 shares0Common StockSEC:0001415889-25-000599:0
3,648 shares@ US$47.9616.7% of flowCommon StockSEC:0000740260-24-000162:0
1,184,688 shares0Common StockSEC:0001209191-24-000807:0
444,444 shares@ US$0.9089.6% of flowCommon StockSEC:0001209191-23-046150:0
Ideal exit: 12 May 2024 (T+270)
3,835 shares@ US$45.6316.6% of flowCommon StockSEC:0000740260-23-000123:0
3,056 shares@ US$57.250.0004% mcap34.4% of flowCommon StockSEC:0000740260-22-000111:0
3,158 shares0Common StockSEC:0000740260-21-000134:0
3,158 shares0Common StockSEC:0000740260-21-000134
1,170 shares@ US$22.350.0012% mcap50.0% of flowCommon StockSEC:0001209191-21-035165:0
Ideal exit: 14 Feb 2022 (T+270)
1,170 shares@ US$22.3550.0% of flowCommon StockSEC:0001209191-21-035165
Ideal exit: 14 Feb 2022 (T+270)
13 of 13 declarations
About Nolan Sean P.
Sean P. Nolan serves as a Board Member at Taysha Gene Therapies, Inc. and Ventas, Inc. He contributes to the governance and strategy of these companies. Taysha Gene Therapies specializes in gene therapies, while Ventas is a provider of healthcare real estate services. Sean P. Nolan brings his expertise to the board, helping to guide strategic decisions and oversee operations.
